These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24119791)

  • 1. Impaired musical ability in people with schizophrenia.
    Hatada S; Sawada K; Akamatsu M; Doi E; Minese M; Yamashita M; Thornton AE; Honer WG; Inoue S
    J Psychiatry Neurosci; 2014 Mar; 39(2):118-26. PubMed ID: 24119791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amusia and cognitive deficits in schizophrenia: is there a relationship?
    Wen Y; Nie X; Wu D; Liu H; Zhang P; Lu X
    Schizophr Res; 2014 Aug; 157(1-3):60-2. PubMed ID: 24957355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Musical deficits and cortical thickness in people with schizophrenia.
    Fujito R; Minese M; Hatada S; Kamimura N; Morinobu S; Lang DJ; Honer WG; Sawada K
    Schizophr Res; 2018 Jul; 197():233-239. PubMed ID: 29454511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Musical cognition in Alzheimer's disease: application of the Montreal Battery of Evaluation of Amusia.
    Campanelli A; Rendace L; Parisi F; D'Antonio F; Imbriano L; de Lena C; Trebbastoni A
    Ann N Y Acad Sci; 2016 Jul; 1375(1):28-37. PubMed ID: 27447536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amusia and protolanguage impairments in schizophrenia.
    Kantrowitz JT; Scaramello N; Jakubovitz A; Lehrfeld JM; Laukka P; Elfenbein HA; Silipo G; Javitt DC
    Psychol Med; 2014 Oct; 44(13):2739-48. PubMed ID: 25066878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
    de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
    Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia.
    F Egan M; Zhao X; Gottwald R; Harper-Mozley L; Zhang Y; Snavely D; Lines C; Michelson D
    Schizophr Res; 2013 May; 146(1-3):224-30. PubMed ID: 23523692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.
    Keefe RS; Goldberg TE; Harvey PD; Gold JM; Poe MP; Coughenour L
    Schizophr Res; 2004 Jun; 68(2-3):283-97. PubMed ID: 15099610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic.
    Kitajima R; Miyamoto S; Tenjin T; Ojima K; Ogino S; Miyake N; Fujiwara K; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Kaneda Y; Yamaguchi N
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):300-6. PubMed ID: 22122880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia.
    Herbener ES; Hill SK; Marvin RW; Sweeney JA
    Am J Psychiatry; 2005 Sep; 162(9):1746-8. PubMed ID: 16135639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy.
    Lipkovich IA; Deberdt W; Csernansky JG; Sabbe B; Keefe RS; Kollack-Walker S
    BMC Psychiatry; 2009 Jul; 9():44. PubMed ID: 19602273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Music-evoked emotions in schizophrenia.
    Abe D; Arai M; Itokawa M
    Schizophr Res; 2017 Jul; 185():144-147. PubMed ID: 28017493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
    Keefe RS; Fox KH; Harvey PD; Cucchiaro J; Siu C; Loebel A
    Schizophr Res; 2011 Feb; 125(2-3):161-8. PubMed ID: 21075600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auditory acuity and musical ability in young adults with high schizotypal traits.
    Deng J; Zheng X; Zhu C; Lin Z; Ye Y
    Compr Psychiatry; 2022 Jan; 114():152297. PubMed ID: 35123176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients.
    Andersen R; Fagerlund B; Rasmussen H; Ebdrup BH; Aggernaes B; Gade A; Oranje B; Glenthoj B
    Eur Psychiatry; 2013 Aug; 28(6):332-9. PubMed ID: 22999439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.
    Rossi A; Mancini F; Stratta P; Mattei P; Gismondi R; Pozzi F; Casacchia M
    Acta Psychiatr Scand; 1997 Jan; 95(1):40-3. PubMed ID: 9051159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory Combination Therapy for the Treatment of Schizophrenia.
    Buchanan RW; Weiner E; Kelly DL; Gold JM; Chen S; Zaranski J; Blatt F; Wehring H; Carpenter WT
    J Clin Psychopharmacol; 2020; 40(5):444-450. PubMed ID: 32796391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.